Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
51.99
-0.85 (-1.61%)
Nov 13, 2024, 4:00 PM EST - Market closed
Janux Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 13, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 2,728 | 495 | 547 | 821 | - | - |
| Market Cap Growth | 409.79% | -9.51% | -33.35% | - | - | - |
| Enterprise Value | 2,094 | 170 | 233 | 434 | - | - |
| Last Close Price | 51.99 | 10.73 | 13.17 | 19.73 | - | - |
| PS Ratio | 204.06 | 61.26 | 63.54 | 225.73 | - | - |
| PB Ratio | 4.15 | 1.44 | 1.71 | 2.24 | - | - |
| P/TBV Ratio | 3.61 | 1.44 | 1.71 | 2.24 | - | - |
| EV/Sales Ratio | 160.46 | 21.08 | 27.00 | 119.25 | - | - |
| Debt / Equity Ratio | 0.04 | 0.07 | 0.08 | 0.00 | - | -1.01 |
| Asset Turnover | 0.02 | 0.02 | 0.02 | 0.02 | - | - |
| Quick Ratio | 38.58 | 26.57 | 19.85 | 29.32 | 4.97 | 0.14 |
| Current Ratio | 38.80 | 26.80 | 20.14 | 29.46 | 5.05 | 0.14 |
| Return on Equity (ROE) | -12.05% | -17.53% | -18.36% | -17.50% | -446.61% | - |
| Return on Assets (ROA) | -9.93% | -12.25% | -11.27% | -10.39% | -35.83% | - |
| Return on Capital (ROIC) | -10.20% | -12.76% | -11.77% | -11.02% | -86.02% | - |
| Earnings Yield | -2.22% | -11.77% | -11.52% | -3.98% | - | - |
| FCF Yield | -1.39% | -10.59% | -9.02% | -2.25% | - | - |
| Buyback Yield / Dilution | -19.85% | -6.14% | -76.24% | -2471.20% | -36.71% | - |
| Total Shareholder Return | -19.85% | -6.14% | -76.24% | -2471.20% | -36.71% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.